DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $19,570,000 | +18.0% | 72,923 | -1.1% | 3.79% | +17.8% |
| Q1 2021 | $16,588,000 | -1.0% | 73,698 | -2.3% | 3.21% | -2.9% |
| Q4 2020 | $16,753,000 | +1.6% | 75,416 | -1.6% | 3.31% | -8.2% |
| Q3 2020 | $16,495,000 | +19.1% | 76,605 | -2.2% | 3.61% | +9.1% |
| Q2 2020 | $13,853,000 | +28.6% | 78,340 | +0.6% | 3.31% | +5.8% |
| Q1 2020 | $10,776,000 | -11.5% | 77,859 | -1.9% | 3.13% | +9.0% |
| Q4 2019 | $12,183,000 | +5.5% | 79,378 | -0.8% | 2.87% | -0.7% |
| Q3 2019 | $11,552,000 | +0.0% | 79,981 | -1.0% | 2.89% | -1.4% |
| Q2 2019 | $11,551,000 | +7.9% | 80,821 | -0.4% | 2.93% | +2.4% |
| Q1 2019 | $10,710,000 | +24.0% | 81,125 | -3.2% | 2.86% | +6.2% |
| Q4 2018 | $8,638,000 | -7.9% | 83,765 | -2.9% | 2.69% | +10.5% |
| Q3 2018 | $9,376,000 | +12.5% | 86,283 | +2.1% | 2.44% | +1.0% |
| Q2 2018 | $8,335,000 | -51.7% | 84,468 | -52.0% | 2.41% | -1.7% |
| Q1 2018 | $17,244,000 | +101.5% | 176,124 | +91.0% | 2.46% | +5.3% |
| Q4 2017 | $8,557,000 | +7.3% | 92,191 | -0.9% | 2.33% | +8.1% |
| Q3 2017 | $7,977,000 | +1.0% | 92,999 | -0.6% | 2.16% | -4.4% |
| Q2 2017 | $7,896,000 | +5.6% | 93,563 | +7.1% | 2.26% | +1.7% |
| Q1 2017 | $7,475,000 | +10.2% | 87,401 | +0.3% | 2.22% | +3.9% |
| Q4 2016 | $6,781,000 | +11.7% | 87,116 | +12.5% | 2.14% | +12.1% |
| Q3 2016 | $6,073,000 | +37.8% | 77,470 | +77.5% | 1.91% | +33.9% |
| Q2 2016 | $4,408,000 | +8.4% | 43,643 | +1.8% | 1.42% | +3.0% |
| Q1 2016 | $4,068,000 | -2.7% | 42,882 | -4.8% | 1.38% | -6.9% |
| Q4 2015 | $4,182,000 | +19.1% | 45,030 | +9.2% | 1.48% | +4.1% |
| Q3 2015 | $3,512,000 | -0.1% | 41,220 | +0.4% | 1.43% | +15.3% |
| Q2 2015 | $3,514,000 | +10.0% | 41,054 | +9.1% | 1.24% | +0.3% |
| Q1 2015 | $3,195,000 | +4.0% | 37,638 | +5.1% | 1.23% | +1.2% |
| Q4 2014 | $3,071,000 | +14.3% | 35,825 | +1.4% | 1.22% | +7.9% |
| Q3 2014 | $2,686,000 | +0.9% | 35,345 | +4.6% | 1.13% | -1.1% |
| Q2 2014 | $2,661,000 | +204.5% | 33,800 | +190.1% | 1.14% | +97.4% |
| Q1 2014 | $874,000 | -13.6% | 11,650 | -11.1% | 0.58% | -14.9% |
| Q4 2013 | $1,011,000 | -11.0% | 13,100 | -20.0% | 0.68% | -18.8% |
| Q3 2013 | $1,136,000 | +12.8% | 16,385 | +3.0% | 0.84% | +1.3% |
| Q2 2013 | $1,007,000 | – | 15,905 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |